KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,329 | -29.0% | 5,434 | -33.7% | 0.00% | – |
| Q2 2023 | $73,728 | +3.1% | 8,192 | -10.0% | 0.00% | – |
| Q1 2023 | $71,526 | +8.3% | 9,100 | -6.9% | 0.00% | – |
| Q4 2022 | $66,052 | -52.8% | 9,771 | +1.1% | 0.00% | – |
| Q3 2022 | $140,000 | +35.9% | 9,661 | -7.7% | 0.00% | – |
| Q2 2022 | $103,000 | -27.5% | 10,467 | +8.7% | 0.00% | – |
| Q1 2022 | $142,000 | -12.9% | 9,631 | -21.7% | 0.00% | – |
| Q4 2021 | $163,000 | -12.8% | 12,298 | +14.6% | 0.00% | – |
| Q3 2021 | $187,000 | -71.5% | 10,733 | -60.8% | 0.00% | -100.0% |
| Q2 2021 | $657,000 | -11.0% | 27,415 | -4.6% | 0.00% | 0.0% |
| Q1 2021 | $738,000 | +76.1% | 28,739 | +30.2% | 0.00% | 0.0% |
| Q4 2020 | $419,000 | +63.0% | 22,080 | +8.2% | 0.00% | – |
| Q3 2020 | $257,000 | +8.4% | 20,406 | +4.4% | 0.00% | – |
| Q2 2020 | $237,000 | +58.0% | 19,546 | 0.0% | 0.00% | – |
| Q1 2020 | $150,000 | -56.4% | 19,546 | +1.2% | 0.00% | -100.0% |
| Q4 2019 | $344,000 | +65.4% | 19,321 | +7.5% | 0.00% | – |
| Q3 2019 | $208,000 | -47.7% | 17,971 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $398,000 | – | 17,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|